176 related articles for article (PubMed ID: 37165402)
1. The combination therapy of isomucronulatol 7-O-beta-glucoside (IMG) and CEP-9722 targeting ferroptosis-related biomarkers in non-small cell lung cancer (NSCLC).
Cui X; Liu C; Dong P; Liu C; Bai Y
BMC Pulm Med; 2023 May; 23(1):162. PubMed ID: 37165402
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients.
Zhang N; Wu Y; Wu Y; Wang L; Chen J; Wang X; Chard Dunmall LS; Cheng Z; Wang Y
Cells; 2022 Jul; 11(14):. PubMed ID: 35883650
[TBL] [Abstract][Full Text] [Related]
3. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
[TBL] [Abstract][Full Text] [Related]
4. Construction of a prognostic model for non-small-cell lung cancer based on ferroptosis-related genes.
Han K; Wang J; Qian K; Zhao T; Liu X; Zhang Y
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33988228
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
Diao X; Guo C; Liu L; Wang G; Li S
Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
[TBL] [Abstract][Full Text] [Related]
6. A prognostic model based on ferroptosis-related long non-coding RNA signatures and immunotherapy responses for non-small cell lung cancer.
Yi WW; Guo XQ; Xu Y; Liang B; Song P
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(6):2591-2604. PubMed ID: 37013777
[TBL] [Abstract][Full Text] [Related]
7. A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma.
Miao TW; Yang DQ; Chen FY; Zhu Q; Chen X
Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35866375
[TBL] [Abstract][Full Text] [Related]
8. Establishment of non-small-cell lung cancer risk prediction model based on prognosis-associated ADME genes.
Han K; Wang J; Qian K; Zhao T; Zhang Y
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34522968
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung Cancer.
Liu T; Luo H; Zhang J; Hu X; Zhang J
BMC Cancer; 2021 Jul; 21(1):783. PubMed ID: 34229636
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of an Immune and Ferroptosis-Combined Index for Non-Small Cell Lung Cancer.
Teng Y; Wang B; Shang D; Yang N
Front Genet; 2021; 12():764869. PubMed ID: 34917129
[No Abstract] [Full Text] [Related]
11. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
Li F; Ge D; Sun SL
BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the ferroptosis-related prognostic biomarker and immune microenvironment of driver gene-negative lung cancer.
Zhou R; Ma HC; Liu YH; Chen X; Chang XS; Chen YD; Liu LR; Li Y; Zhu YJ; Zhang HB
Exp Biol Med (Maywood); 2022 Aug; 247(16):1447-1465. PubMed ID: 35762414
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
Song Z; Jia G; Ma P; Cang S
Life Sci; 2021 Jul; 276():119399. PubMed ID: 33781830
[TBL] [Abstract][Full Text] [Related]
14. A survival model for prognostic prediction based on ferroptosis-associated genes and the association with immune infiltration in lung squamous cell carcinoma.
Lu Y; Yang H; Cao Y; Wang Y; Wu M; He B; Xu J; Su Z; Luo W; Liu Y; Hu W
PLoS One; 2023; 18(3):e0282888. PubMed ID: 36928232
[TBL] [Abstract][Full Text] [Related]
15. Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer.
Ding H; Shi L; Chen Z; Lu Y; Tian Z; Xiao H; Deng X; Chen P; Zhang Y
BMC Med Genomics; 2022 Sep; 15(1):187. PubMed ID: 36056349
[TBL] [Abstract][Full Text] [Related]
16. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-related gene AKR1C1 predicts the prognosis of non-small cell lung cancer.
Huang F; Zheng Y; Li X; Luo H; Luo L
Cancer Cell Int; 2021 Oct; 21(1):567. PubMed ID: 34702254
[TBL] [Abstract][Full Text] [Related]
18. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
19. Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer.
Ma Q; Geng K; Xiao P; Zeng L
Biomed Res Int; 2021; 2021():5963868. PubMed ID: 34518802
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer.
Yang CZ; Hu LH; Huang ZY; Deng L; Guo W; Liu S; Xiao X; Yang HX; Lin JT; Sun LL; Lin LZ
PLoS One; 2021; 16(12):e0260720. PubMed ID: 34855841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]